default author photo

Aminata Bagayoko

World Health Organization (WHO)

Abuja

Nigeria

SCHOLARLY PAPERS

1

DOWNLOADS

102

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Rvsv-Zebov Vaccination in People with Pre-Existing Immunity to Ebolavirus: An Open-Label Safety and Immunogenicity Study in Guinean Communities Affected by Ebola Virus Disease (L’Essai Proches)

Number of pages: 18 Posted: 09 May 2024
UK Health Security Agency, World Health Organization (WHO), UK Health Security Agency, Epicentre (Paris), World Health Organization (WHO), World Health Organization (WHO), Pan American Health Organization, World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), Bernhard-Nocht-Institute for Tropical Medicine (BNITM), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), Gamal Abdel Nasser University, World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), World Health Organization (WHO), University of Oxford - Pandemic Sciences Institute, London School of Hygiene & Tropical Medicine - Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine - Department of Clinical Research, London School of Hygiene & Tropical Medicine, University of Marburg, Bernhard-Nocht-Institute for Tropical Medicine (BNITM), World Health Organization (WHO), London School of Hygiene & Tropical Medicine, University of Oxford - Wellcome Trust Centre for Human Genetics and Independent
Downloads 102 (679,608)

Abstract:

Loading...

Ebola virus disease, Ebola, vaccine, rVSV-ZEBOV, safety, immunogenicity, cohort study